APHINITY Trial: Pertuzumab for Patients with HER2+ Breast Cancer

Opinion
Video

Dr Shatsky discusses pertuzumab as a treatment for patients with HER2+ breast cancer, highlighting its mechanism of action as a HER2 dimerization inhibitor and updated data from the APHINITY trial.

Recent Videos
1 KOL is featured in this series.
1 expert in this video
1 expert in this video
4 experts are featured in this series.
Related Content